Objective: Anal cancer precursor lesions high-grade anal intraepithelial neoplasia (HGAIN)
are highly prevalent among HIV+ MSM. Treatment of HGAIN is frustrated by high recurrence …

Introduction Persistent human papillomavirus infection is an important factor in the
development of cervical cancer, which is usually a long process evolving from the …

Background Efficacy of the nine-valent human papillomavirus (9vHPV; HPV types
6/11/16/18/31/33/45/52/58) vaccine was demonstrated in a phase 3 study in women 16–26 …

Vaccines used to prevent infections have long been known to stimulate immune responses
to cancer as illustrated by the approval of the Bacillus Calmette–Guérin (BCG) vaccine to …

Data suggest that adjuvant human papillomavirus (HPV)-vaccination in women treated for
cervical HPV diseases reduces recurrent disease. This study investigates adjuvant HPV …

High-risk human papillomavirus (hrHPV) infection is the cause of most cervical cancers.
Since therapeutic vaccines are not yet available for clinical practice, the administration of …

The introduction of human papillomavirus vaccines revolutionized cervical cancer
prevention. Our research hypothesis is that HPV vaccination affects the remission of HPV in …

Background: Recent data have shown that the human papillomavirus (HPV) vaccine could
impact on a decrease in high-grade cervical intraepithelial lesions (HSIL) in women who …

Specific adult populations known to be at high risk for human papillomavirus (HPV)-related
disease, such as men who have sex with men, are inconsistently included in national …

Cervical cancer is one of the leading causes of cancer-related death in women of
reproductive age. The established fertility-sparing approaches for the management of early …